SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies. Reincke SM, Yuan M, Kornau HC, Corman VM, et al. Science 2022 Jan 25:eabm5835. doi: 10.1126/science.abm5835.

Read + Share

Amedeo Smart

Independent Medical Education

Reincke SM, Yuan M, Kornau HC, Corman VM, et al. SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies. Science 2022 Jan 25:eabm5835. doi: 10.1126/science.abm5835.
PMID: 35076281